DAIC

JUNE 13, 2024

This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management. It’s an excellent choice for cardiac surgeons and their patients seeking an aortic valve solution that can be fit for the future, right from the start. 5 Verbelen T, Roussel JC, Cathenis K, et al.,

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109

Open Heart

MAY 8, 2023

Objectives To explore the ethnic differences in patients undergoing aortic valve (AV) intervention for severe aortic stenosis (AS) in Leicestershire, UK. Results Of the 1231 SAVR and 815 TAVI performed, 6.5% were in ethnic minority patients, respectively.

Aortic valve 52

Aortic valve Aortic Stenosis Research 52

Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

RAA features were characterised by comparing prenatal ultrasound data with anatomical casting results after pregnancy termination or postnatal imaging and surgical intervention to analyse the prognosis and misdiagnoses of fetal RAA.ResultsOf the 157 fetal RAA cases, 50 (31.8%) cases were isolated RAA and 107 (68.2%) cases were nonisolated RAA.

Ultrasound 52

Ultrasound Aortic Outcomes Anatomy 52

DAIC

FEBRUARY 3, 2025

Lp(a) is emerging as an important, yet under-recognized, potential risk factor for cardiovascular disease due to its ability to promote the development of plaques within artery walls, clot formation and aortic valve calcification. 2022 Aug, 80 (9) 934946 Kronenberg F.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

Open Heart

SEPTEMBER 18, 2024

Backgrounds Permanent pacemaker implantation (PPMI) is one of the greatest disadvantages of transcatheter aortic valve implantation (TAVI). Methods We retrospectively analysed data from 745 consecutive patients who underwent TAVI for severe aortic stenosis from November 2013 to July 2022.

Aortic valve 52

Aortic valve Pacemaker Aortic Heart Failure 52

Frontiers in Cardiovascular Medicine

FEBRUARY 29, 2024

Objective The initial operation for type A aortic dissection has limitations, and there may be a need for reoperation in cases such as giant pseudoaneurysm formation and reduced blood supply to the distal vessels. In this study, we retrospectively analyzed the recorded data of 62 patients.

Aortic 49

Aortic Quality of Life Stents Stent 49

DAIC

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves. Evolut vs. 10.6%

TAVR 111

TAVR Aortic valve Aortic Stenosis 111

Dr. S. Venkatesan MD

APRIL 10, 2024

A 76-year-old woman with a history of double valve replacement (Aortic and mitral valves) for rheumatic heart disease, presented with acute dyspnea after a switch from Warfarin to LMWH before a planned bone marrow biopsy. The investigations revealed a stuck aortic prosthetic valve ,that showed a prohibitive gradient of more than 50 mmhg.

Aortic valve 52

Aortic valve Aortic Thrombosis Bicuspid/Mitral 52

Circulation

MARCH 29, 2025

Background: Symptomatic severe aortic stenosis (AS) remains undertreated with high resultant mortality despite increased growth and availability of aortic valve replacement (AVR) since the advent of transcatheter therapies. The patient cohort had mean age of 7711 years, was 47% female, and had mean aortic valve area 0.80.1

Aortic 45

Aortic Aortic valve Stenosis Academic 45

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035). Poverall=0.522; 1 year: 10% versus 2.3%

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Circulation

OCTOBER 23, 2024

BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aortic valve replacement (SAVR) in patients with bicuspid aortic valve (BAV) aortic stenosis (AS) versus patients with tricuspid aortic valve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

ObjectiveThis study aims to summarize the clinical experience of using Hem-o-lok clips for the closure of the left subclavian artery (LSA) stump in patients with acute Stanford type A aortic dissection.MethodsClinical data were collected from 96 patients with acute type A aortic dissection admitted to our hospital from January 2020 to December 2022.

Aortic 52

Aortic Thrombosis Aneurysm Stents 52

Circulation: Cardiovascular Interventions

APRIL 7, 2025

BACKGROUND:The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aortic valve replacement (AVR). Patients were categorized into 5 groups (stages 04) based on their stage of cardiac damage in the year before AVR.

Aortic valve 40

Aortic valve Aortic Heart Failure Quality of Life 40

Open Heart

DECEMBER 9, 2023

Objective Cabrol shunt has been introduced for surgical repair of type A aortic dissection (TAAD) without robust evidence supporting its routine preventive use. Methods Adult patients with TAAD from China 5A study were included if surgically repaired between 2016 and 2022. Results were similar in multiple sensitivity analysis.

Aortic 52

Aortic Outcomes 52

CardiacWire

JANUARY 31, 2024

Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. Much of these SAVR declines occurred in patients with tricuspid aortic valves (from 84.5%

TAVR 69

TAVR Aortic valve Bicuspid/Mitral Aortic 69

Heart BMJ

DECEMBER 15, 2023

Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgical procedure that has revolutionised the treatment of severe aortic stenosis (AS). It is a serious condition that can significantly impair quality of life and lead to fatal cardiovascular complications if left unmanaged.

Aortic valve 40

Aortic valve Pulmonary Aortic Quality of Life 40

Open Heart

MAY 17, 2022

Objectives The management of severe aortic stenosis mandates consideration of aortic valve intervention for symptomatic patients. However, for asymptomatic patients with severe aortic stenosis, recent randomised trials supported earlier intervention. to 0.96; I 2 15%). to 0.56; I 2 77%).

Stenosis 40

Stenosis Aortic Aortic valve Heart Failure 40

Journal of the American Heart Association

FEBRUARY 3, 2025

BackgroundMalnutrition status is an important predictor of prognosis in patients after aortic valve replacement. However, the prognostic value of malnutrition status in patients with moderatetosevere aortic stenosis is unclear. Patients were grouped according to different nutritional status assessment methods.

Stenosis 40

Stenosis Aortic Aortic valve Academic 40

Open Heart

MARCH 27, 2024

Objective A paucity of data exists on how transcatheter aortic valve implantation (TAVI) practice has evolved in Ireland. This study sought to analyse temporal trends in patient demographics, procedural characteristics, and clinical outcomes at an Irish tertiary referral centre. mean Society of Thoracic Surgeons score 5.9±5.1).

Aortic valve 52

Aortic valve Aortic Outcomes Hospital 52

DAIC

MAY 8, 2024

Recommendations Plan for alternative capital equipment to transition away from these Getinge cardiovascular devices: Getinge/Maquet/Datascope Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices. The device is an electromechanical system used to inflate and deflate intra-aortic balloons. for the Cardiosave IABP.

Certification 98

Certification Aortic Education Circulation 98

Journal of Cardiothoracic Surgery

NOVEMBER 13, 2024

Background To investigate the contemporary comparative inpatient prognosis among US and Chinese patients with type A aortic dissection (TAAD). Trial registration KY20220425-05, April 5th 25 2022. Methods Data from Chinese multi-institutional TAAD registry and the US National Inpatient Sample databases were analyzed.

Inpatient 52

Inpatient Aortic Outcomes Hospital 52

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundAcute ischemic stroke complicates 2% to 3% of transcatheter aortic valve replacements (TAVRs). This study aimed to identify the aortic anatomic correlates in patients after TAVR stroke.Methods and ResultsThis is a single‐center, retrospective study of patients who underwent TAVR at the Mayo Clinic between 2012 and 2022.

Aortic valve 40

Aortic valve Anatomy Aortic TAVR 40

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Circulation: Cardiovascular Interventions, Ahead of Print. Exposure of interest was PVD. Primary outcome was all-cause mortality.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of the American Heart Association

NOVEMBER 28, 2023

BackgroundComplex aortic plaque (CAP) is a potential embolic source in patients with cryptogenic stroke (CS). Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. Two independent reviewers extracted data on study design, imaging techniques, CAP criteria, and prevalence.

Plaque 40

Plaque Biomarkers Aortic Stroke 40

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 13, 2023

The primary outcome was a composite of all-cause mortality or hospital readmission within 1 year.

TAVR 40

TAVR Aortic valve Aortic Outcomes 40

Frontiers in Cardiovascular Medicine

MAY 19, 2024

BackgroundThe use of Intra-aortic Balloon Pump (IABP) and Impella devices as a bridge to heart transplantation (HTx) has increased significantly in recent times. We used the eXtreme Gradient Boosting (XGBoost) algorithm to build and validate ML models.

Heart Transplant 59

Heart Transplant Transplant BMI Aortic 59

European Journal of Heart Failure

DECEMBER 13, 2023

Patients with significant pulmonary oedema or aortic valve (AV) closure during venoarterial extracorporeal membrane oxygenation (VA-ECMO) were randomized to early left ventricular (LV) unloading or conventional strategy groups (1:1). The primary endpoint was the rate of weaning from VA-ECMO during index admission.

Aortic valve 75

Aortic valve Cardiac Arrest Heart Transplant Pulmonary 75

Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2024

Methods This study analyzed 2,771 publications related to patient management after valve replacement published in the Web of Science Core Collection database between January 1, 2013, and December 31, 2022. Transcatheter aortic valve replacement was a current research hotspot, while anticoagulation management was a key area of interest.

Research 59

Research Aortic valve Artificial Heart Heart Valves 59

Journal of the American Heart Association

FEBRUARY 3, 2025

The primary outcome was inhospital mortality, and the secondary outcomes included the length of hospital stay, length of ECMO, total hospitalization cost, complications, and durable mechanical circulatory support implantations.

Inpatient 45

Inpatient Aortic Hospital Outcomes 45

Frontiers in Cardiovascular Medicine

DECEMBER 14, 2023

Objective The objective of this study was to perform a network meta-analysis (NMA) to assess the efficacy and safety of three different surgical interventions- open surgical repair (OSR), hybrid surgical repair (HSR), and endovascular repair (EVAR)- for the treatment of thoracoabdominal aortic aneurysms (TAAAs).

Aneurysm 64

Aneurysm Aortic Hospital Outcomes 64

DAIC

APRIL 1, 2024

Cholesterol may cause or exacerbate some types of valvular heart disease, so drug companies are testing statins and PSK9 inhibitors (which lower cholesterol even more than statins) against aortic stenosis.

Technology 105

Technology Heart Disease Innovation Ultrasound 105

Dr. Smith's ECG Blog

FEBRUARY 6, 2024

Retrieved July 2, 2022, from [link] Moyé, D. Retrieved July 2, 2022, from [link] Sybrandy, K. Retrieved July 2, 2022, from [link] == MY Comment , by K EN G RAUER, MD ( 2/4 /2024 ): == Today's case by Dr. The ST-T wave in leads V5,V6 looks to be disproportionately large ( ie, hyperacute ) given QRS amplitude in these leads.

Tachycardia 115

Tachycardia Dysrhythmia Atrial Fibrillation Bradycardia 115

Frontiers in Cardiovascular Medicine

DECEMBER 12, 2024

33 preoperative clinical features and 4 postoperative complications were collected in each group. LASSO is a regression analysis method that performs both variable selection and regularization to enhance model prediction accuracy and interpretability.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Stroke Strokes Aortic 52

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

Predictive variables were selected based on clinical expertise and prior literature, and a nomogram was developed using LASSO regression and multiple logistic regression.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Aortic Hospital Outcomes 52

Cardiology Update

NOVEMBER 26, 2023

In light of the growing number of patients undergoing transcatheter aortic valve replacement (TAVR), there is an increasing demand for data regarding the management of failed TAVR procedures, including the possibility of a repeat TAVR intervention. No significant disparities were found in the rates of death at 30 days (4.7%

TAVR 52

TAVR Aortic valve Outcomes Aortic 52

Heart BMJ

MAY 10, 2024

Methods The baseline, perioperative and follow-up data were obtained for all paediatric patients with conotruncal defects who underwent BDG procedure as palliation in Fuwai Hospital from 2013 to 2022. Patients with single ventricle were excluded. The primary outcome was mortality. years (IQR: 2.72–5.42) in the overall cohort, 3.62

Cardiovascular Surgery 52

Cardiovascular Surgery Risk Factors Aortic Hospital 52